CF
RMD icon

Corebridge Financial’s ResMed RMD Stock Holding History

Corebridge Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,551
Closed -$9.08M – 2215
2025
Q1 		$9.08M Sell
40,551
-1,741
-4% -$406K 0.05% 386
2024
Q4 		$9.67M Buy
42,292
+3,673
+10% +$884K 0.05% 394
2024
Q3 		$9.43M Sell
38,619
-1,072
-3% -$240K 0.05% 432
2024
Q2 		$7.6M Buy
+39,691
New +$8.05M 0.04% 531

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Corebridge Financial's RMD Position: Q2 2025 in Review

Corebridge Financial sold out of ResMed (RMD) in Q2 2025, closing a stake of 40,551 shares — an estimated $9.08M sold.

Corebridge Financial first reported a position in RMD in Q2 2024 and held it in 4 quarters. The position peaked at $9.67M in Q4 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Corebridge Financial reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 40,551 ResMed shares in Q2 2025, an estimated $9.08M.
  • Corebridge Financial first reported a position in ResMed in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's ResMed position peaked at $9.67M in Q4 2024.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.